Precision drugs and gene therapy treatments to activate pro-survival pathways in selected neuronal populations

We investigate molecular mechanisms promoting functional maintenance of dopaminergic neurons, a neuronal population predominantly affected in Parkinson’s disease patients. We are aiming to find novel drugs and therapeutic strategies to support survival of dopaminergic neurons and protect them from cellular stress and pathological protein aggregation.
@ADom_Lab

WOW! What a way to start the week (& new year)! @ParkinsonsDoc @foltynie Prof Schapira & @UCLIoN colleagues presen… twitter.com/i/web/status/1…

This was an unexpected and interesting phenotype and links CDNF to important PD symptom. Great work and effort from… twitter.com/i/web/status/1…

The most excellent way to start a new year!!! Thank you Jane & Aatos Erkko foundation for granting me the 3 year fu… twitter.com/i/web/status/1…

The future of stem cell therapies for #Parkinsons by @ParmarLab @s_grealish & Claire Henchcliffe @WeillCornelltwitter.com/i/web/status/1…

Recent publications

RSS Feed

No results.